Abstract P1-01-02: Circulating tumor cells (CTC) and endothelial cells (CEC) prognostic value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: First results of a prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG): COMET study

Author(s):  
J-Y Pierga ◽  
O Tredant ◽  
M Chevrier ◽  
C Dubot ◽  
V Lorgis ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document